Cargando…

Cellular models of Batten disease

The Neuronal Ceroid Lipofuscinoses (NCL), otherwise known as Batten disease, are a group of neurodegenerative diseases caused by mutations in 13 known genes. All except one NCL is autosomal recessive in inheritance, with similar aetiology and characterised by the accumulation of autofluorescent stor...

Descripción completa

Detalles Bibliográficos
Autores principales: Minnis, Christopher J., Thornton, Christopher D., FitzPatrick, Lorna M., McKay, Tristan R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338907/
https://www.ncbi.nlm.nih.gov/pubmed/31655107
http://dx.doi.org/10.1016/j.bbadis.2019.165559
_version_ 1783554782763417600
author Minnis, Christopher J.
Thornton, Christopher D.
FitzPatrick, Lorna M.
McKay, Tristan R.
author_facet Minnis, Christopher J.
Thornton, Christopher D.
FitzPatrick, Lorna M.
McKay, Tristan R.
author_sort Minnis, Christopher J.
collection PubMed
description The Neuronal Ceroid Lipofuscinoses (NCL), otherwise known as Batten disease, are a group of neurodegenerative diseases caused by mutations in 13 known genes. All except one NCL is autosomal recessive in inheritance, with similar aetiology and characterised by the accumulation of autofluorescent storage material in the lysosomes of cells. Age of onset and the rate of progression vary between the NCLs. They are collectively one of the most common lysosomal storage diseases, but the enigma remains of how genetically distinct diseases result in such remarkably similar pathogenesis. Much has been learnt from cellular studies about the function of the proteins encoded by the affected genes. Such research has utilised primitive unicellular models such as yeast and amoeba containing gene orthologues, cells derived from naturally occurring (sheep) and genetically engineered (mouse) animal models or patient-derived cells. Most recently, patient-derived induced pluripotent stem cell (iPSC) lines have been differentiated into neural cell-types to study molecular pathogenesis in the cells most profoundly affected by disease. Here, we review how cell models have informed much of the biochemical understanding of the NCLs and how more complex models are being used to further this understanding and potentially act as platforms for therapeutic efficacy studies in the future.
format Online
Article
Text
id pubmed-7338907
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-73389072020-09-01 Cellular models of Batten disease Minnis, Christopher J. Thornton, Christopher D. FitzPatrick, Lorna M. McKay, Tristan R. Biochim Biophys Acta Mol Basis Dis Article The Neuronal Ceroid Lipofuscinoses (NCL), otherwise known as Batten disease, are a group of neurodegenerative diseases caused by mutations in 13 known genes. All except one NCL is autosomal recessive in inheritance, with similar aetiology and characterised by the accumulation of autofluorescent storage material in the lysosomes of cells. Age of onset and the rate of progression vary between the NCLs. They are collectively one of the most common lysosomal storage diseases, but the enigma remains of how genetically distinct diseases result in such remarkably similar pathogenesis. Much has been learnt from cellular studies about the function of the proteins encoded by the affected genes. Such research has utilised primitive unicellular models such as yeast and amoeba containing gene orthologues, cells derived from naturally occurring (sheep) and genetically engineered (mouse) animal models or patient-derived cells. Most recently, patient-derived induced pluripotent stem cell (iPSC) lines have been differentiated into neural cell-types to study molecular pathogenesis in the cells most profoundly affected by disease. Here, we review how cell models have informed much of the biochemical understanding of the NCLs and how more complex models are being used to further this understanding and potentially act as platforms for therapeutic efficacy studies in the future. Elsevier 2020-09-01 /pmc/articles/PMC7338907/ /pubmed/31655107 http://dx.doi.org/10.1016/j.bbadis.2019.165559 Text en © 2019 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Minnis, Christopher J.
Thornton, Christopher D.
FitzPatrick, Lorna M.
McKay, Tristan R.
Cellular models of Batten disease
title Cellular models of Batten disease
title_full Cellular models of Batten disease
title_fullStr Cellular models of Batten disease
title_full_unstemmed Cellular models of Batten disease
title_short Cellular models of Batten disease
title_sort cellular models of batten disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338907/
https://www.ncbi.nlm.nih.gov/pubmed/31655107
http://dx.doi.org/10.1016/j.bbadis.2019.165559
work_keys_str_mv AT minnischristopherj cellularmodelsofbattendisease
AT thorntonchristopherd cellularmodelsofbattendisease
AT fitzpatricklornam cellularmodelsofbattendisease
AT mckaytristanr cellularmodelsofbattendisease